Unknown

Dataset Information

0

MiR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.


ABSTRACT: FLT3-ITD+ acute myeloid leukemia (AML) accounts for ?25% of all AML cases and is a subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically overexpressed in FLT3-ITD+ AML compared with FLT3 wild-type (FLT3-WT) AML and is critical for the growth of FLT3-ITD+ AML cells in vitro. However, miR-155's role in regulating FLT3-ITD-mediated disease in vivo remains unclear. In this study, we used a genetic mouse model to determine whether miR-155 influences the development of FLT3-ITD-induced myeloproliferative disease. Results indicate that miR-155 promotes FLT3-ITD-induced myeloid expansion in the bone marrow, spleen, and peripheral blood. Mechanistically, miR-155 increases proliferation of the hematopoietic stem and progenitor cell compartments by reducing the growth-inhibitory effects of the interferon (IFN) response, and this involves targeting of Cebpb. Consistent with our observations in mice, primary FLT3-ITD+ AML clinical samples have significantly higher miR-155 levels and a lower IFN response compared with FLT3-WT AML samples. Further, inhibition of miR-155 in FLT3-ITD+ AML cell lines using CRISPR/Cas9, or primary FLT3-ITD+ AML samples using locked nucleic acid antisense inhibitors, results in an elevated IFN response and reduces colony formation. Altogether, our data reveal that miR-155 collaborates with FLT3-ITD to promote myeloid cell expansion in vivo and that this involves a multitarget mechanism that includes repression of IFN signaling.

SUBMITTER: Wallace JA 

PROVIDER: S-EPMC5465836 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications


FLT3-ITD<sup>+</sup> acute myeloid leukemia (AML) accounts for ∼25% of all AML cases and is a subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically overexpressed in FLT3-ITD<sup>+</sup> AML compared with FLT3 wild-type (FLT3-WT) AML and is critical for the growth of FLT3-ITD<sup>+</sup> AML cells in vitro. However, miR-155's role in regulating FLT3-ITD-mediated disease in vivo remains unclear. In this study, we used a genetic mouse model to determine whether miR-155 influ  ...[more]

Similar Datasets

| S-EPMC8973317 | biostudies-literature
| S-EPMC9809327 | biostudies-literature
| S-EPMC6278956 | biostudies-literature
2017-09-08 | GSE86526 | GEO
| S-EPMC5045383 | biostudies-literature
| S-EPMC4868182 | biostudies-literature
| S-EPMC3725984 | biostudies-literature
| S-EPMC8141515 | biostudies-literature
| S-EPMC5519068 | biostudies-other
| S-EPMC5629368 | biostudies-literature